Re: Farmas USA
ADXS
May 5, 2015 underwritten public offering of 2,800,000 shares of its common stock at a public offering price of $19.00 per share. The gross proceeds to Advaxis from the public offering were $53,200,000, before underwriting discounts and commissions and other estimated offering expenses.
Cash 47 millones a los que habría que añadir esos 53 que entiendo posteriores al 30 de abril de 2015 (me parece que sus trimestres no son los habituales de marzo, junio, etc). Quemado de caja bastante variable, el último de casi 14 millones
http://ir.advaxis.com/all-sec-filings#document-120755-0001493152-15-002480